Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy

G Delouya, V Krishnan, JP Bahary, S Larrivée… - Urology, 2014 - Elsevier
Objective To analyze the value of the Cancer of the Prostate Risk Assessment (CAPRA)
score to predict biochemical failure (bF) in patients with D'Amico low-or intermediate-risk …

The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of …

S Halverson, M Schipper, K Blas, V Lee… - Radiotherapy and …, 2011 - Elsevier
BACKGROUND: The Cancer of the Prostate Risk Assessment (CAPRA) was developed to
predict freedom from biochemical failure (FFBF) following radical prostatectomy (RP). Its …

The C ancer of the P rostate R isk A ssessment (CAPRA) score predicts biochemical recurrence in intermediate‐risk prostate cancer treated with external beam …

V Krishnan, G Delouya, JP Bahary, S Larrivée… - BJU …, 2014 - Wiley Online Library
Objective To study the prognostic value of the U niversity of C alifornia, S an F rancisco C
ancer of the P rostate R isk A ssessment (CAPRA) score to predict biochemical failure (bF) …

Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen …

DL Fitch, S McGrath, AA Martinez, FA Vicini… - International Journal of …, 2006 - Elsevier
Purpose: Minimal data are available regarding selection of an optimal biochemical failure
(BF) definition for patients treated with brachytherapy, external beam radiotherapy (EBRT) …

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy

AY Ho, RJ Burri, JA Cesaretti, NN Stone… - International Journal of …, 2009 - Elsevier
PURPOSE: To evaluate the influence of patient-and treatment-related factors on freedom
from biochemical failure (FFbF) in patients with intermediate-risk prostate cancer. METHODS …

Comparison of the Biochemical Recurrence risk between Radical Prostatectomy and Brachytherapy in the treatment of low-and intermediate-risk prostate cancer

PF Martinez, DF Belisle, C Cristallo, I Tobia… - Archivos Espanoles …, 2015 - europepmc.org
Objectives To evaluate the results of patients treated with Radical Prostatectomy (RP) and
Brachytherapy for low-and intermediate-risk localized prostate cancer and to determine the …

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external …

EM Horwitz, FA Vicini, EL Ziaja, CF Dmuchowski… - International Journal of …, 1998 - Elsevier
Purpose: We reviewed our institution's experience treating patients with external beam
irradiation (RT) to determine if the ASTRO Consensus Panel definition of biochemical failure …

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled …

EM Horwitz, HD Thames, DA Kuban, LB Levy… - The Journal of …, 2005 - auajournals.org
ABSTRACT Purpose: Pooled data on 4,839 patients with T1-2 prostate cancer treated with
external beam radiation therapy (RT) alone at 9 institutions have previously provided long …

Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer

MK Buyyounouski, AL Hanlon, DF Eisenberg… - International Journal of …, 2005 - Elsevier
Purpose: To compare several characteristics of alternative definitions of biochemical failure
(BF) in men with extended follow-up after radiotherapy (RT) with or with androgen …

Limitations of the cancer of the prostate risk assessment (CAPRA) prognostic tool for prediction of metastases and prostate cancer-specific mortality in patients treated …

JM Vainshtein, M Schipper, S Vance… - American Journal of …, 2016 - journals.lww.com
Objectives: To assess the performance of the Cancer of the Prostate Risk Assessment
(CAPRA) prognostic tool for freedom-from-metastases (FFM) and cause-specific survival …